{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34351367", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "11"}, "DateRevised": {"Year": "2021", "Month": "08", "Day": "25"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["7", "10.1167/tvst.10.9.7"], "Journal": {"ISSN": "2164-2591", "JournalIssue": {"Volume": "10", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "02"}}, "Title": "Translational vision science & technology", "ISOAbbreviation": "Transl Vis Sci Technol"}, "ArticleTitle": "COVID-19 Ocular Prophylaxis: The Potential Role of Ozonated-Oils in Liposome Eyedrop Gel.", "Pagination": {"StartPage": "7", "MedlinePgn": "7"}, "Abstract": {"AbstractText": ["To assess whether ozonated-oil in liposome eyedrop gel (OED) could be used to prevent the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection in an in vitro infection model.", "First, we tested the efficacy of OED on in vitro cell regeneration and dry eye resolution in human corneal epithelial cells (hCE-2). Second, we assessed the in vitro anti-SARS-CoV-2 infection efficacy of OED using Vero E6 cells. Tissues were examined to assess different parameters: morphology, histology, and mRNA expression at 24 hours after treatment.", "OED could restore 50% of the scratch in the monolayer of hCE-2 cells in vitro compared with the 25% obtained with phosphate-buffered saline solution (PBS). At 24 hours after treatment with OED, the number of microvilli and the mucin network were restored, as observed using scanning electron microscopy. In Vero E6 cells infected with a primary SARS-CoV-2 strain and treated with OED two times/day, viral replication was found to be inhibited, with a 70-fold reduction observed at 72 hours after infection compared with that under the untreated and PBS-treated conditions.", "SARS-CoV-2 transmission through the ocular surface should not be ignored. Although the prevalence of coronavirus disease 2019 conjunctivitis infection is low, the need for a barrier to prevent possible viral infection is warranted. OED treatment may prevent the risk of SARS-CoV-2 infection after 72 hours of twice-daily applications.", "Dry eye condition might be a risk factor for SARS-CoV-2 infection and OED treatment may have a preventive role."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Ophthalmology, \"Fondazione Policlinico A Gemelli IRCCS,\" Rome, Italy."}, {"Identifier": [], "Affiliation": "\"Universit\u00e0 Cattolica Sacro Cuore\", Rome, Italy."}, {"Identifier": [], "Affiliation": "Consiglio Nazionale delle Ricerche (CNR), Istituto di Neuroscienze, Pisa, Italy."}], "LastName": "Rizzo", "ForeName": "Stanislao", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Ophthalmology, \"Fondazione Policlinico A Gemelli IRCCS,\" Rome, Italy."}, {"Identifier": [], "Affiliation": "\"Universit\u00e0 Cattolica Sacro Cuore\", Rome, Italy."}], "LastName": "Savastano", "ForeName": "Maria Cristina", "Initials": "MC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ferrara, Department of Chemical, Pharmaceutical and Agricultural Sciences, Ferrara, Italy."}], "LastName": "Bortolotti", "ForeName": "Daria", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Ophthalmology, \"Fondazione Policlinico A Gemelli IRCCS,\" Rome, Italy."}, {"Identifier": [], "Affiliation": "\"Universit\u00e0 Cattolica Sacro Cuore\", Rome, Italy."}], "LastName": "Savastano", "ForeName": "Alfonso", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Ophthalmology, \"Fondazione Policlinico A Gemelli IRCCS,\" Rome, Italy."}, {"Identifier": [], "Affiliation": "\"Universit\u00e0 Cattolica Sacro Cuore\", Rome, Italy."}], "LastName": "Gambini", "ForeName": "Gloria", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Virology, \"Spedali Civili,\" Brescia, Italy."}], "LastName": "Caccuri", "ForeName": "Francesca", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ferrara, Department of Chemical, Pharmaceutical and Agricultural Sciences, Ferrara, Italy."}], "LastName": "Gentili", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Ferrara, Department of Chemical, Pharmaceutical and Agricultural Sciences, Ferrara, Italy."}], "LastName": "Rizzo", "ForeName": "Roberta", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Transl Vis Sci Technol", "NlmUniqueID": "101595919", "ISSNLinking": "2164-2591"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Liposomes"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils"}, {"RegistryNumber": "0", "NameOfSubstance": "Ophthalmic Solutions"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Liposomes"}, {"QualifierName": [], "DescriptorName": "Oils"}, {"QualifierName": [], "DescriptorName": "Ophthalmic Solutions"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "Disclosure: <b>S. Rizzo,</b> None; <b>M.C. Savastano,</b> None; <b>D. Bortolotti,</b> None; <b>A. Savastano,</b> None; <b>G. Gambini,</b> None; <b>F. Caccuri,</b> None; <b>V. Gentili,</b> None; <b>R. Rizzo,</b> None"}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lu CW, Liu X, Jia ZF.. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020; e39: 395.", "ArticleIdList": ["PMC7133551", "32035510"]}, {"Citation": "Chen L, Liu M, Zhang Z, et al. .. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020; 104: 748\u2013751.", "ArticleIdList": ["PMC7211077", "32265202"]}, {"Citation": "Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; 92: 589\u2013594.", "ArticleIdList": ["PMC7228294", "32100876"]}, {"Citation": "Bozkurt E, \u00d6zate\u015f S, Muhaf\u0131z E, et al. .. Ocular surface and conjunctival cytology findings in patients with confirmed COVID-19. Eye Contact Lens Sci Clin Pract. 2021; 47(4): 168\u2013173.", "ArticleIdList": ["33060413"]}, {"Citation": "Valente P, Iarossi G, Federici M, et al. .. Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J Am Assoc Pediatr Ophthalmol Strabismus. 2020; 24: 212\u2013215.", "ArticleIdList": ["PMC7282793", "32531341"]}, {"Citation": "Coroneo MT.The eye as the discrete but defensible portal of coronavirus infection. Ocul Surf. 2021; 19: 176\u2013182.", "ArticleIdList": ["PMC7241406", "32446866"]}, {"Citation": "Yang J, Petitjean SJL, Koehler M, et al. .. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nat Commun. 2020; 11: 4541.", "ArticleIdList": ["PMC7486399", "32917884"]}, {"Citation": "Araimo F, Imperiale C, Tordiglione P, et al. .. Ozone as adjuvant support in the treatment of COVID-19: a preliminary report of probiozovid trial. J Med Virol. 2020; 93: 2210\u20132220", "ArticleIdList": ["33111980"]}, {"Citation": "Elvis AM, Ekta JS.. Ozone therapy: a clinical review. J Nat Sci Biol Med .2011; 2(1): 66\u201370.", "ArticleIdList": ["PMC3312702", "22470237"]}, {"Citation": "Cattel F, Giordano S, Bertiond C, et al. .. Ozone therapy in COVID-19: a narrative review. Virus Res .2021; 291: 198207.", "ArticleIdList": ["PMC7585733", "33115670"]}, {"Citation": "Kim HS, Noh SU, Han YW, et al. .. Therapeutic effects of topical application of ozone on acute cutaneous wound healing. J Korean Med Sci. 2009; 24: 368\u2013374.", "ArticleIdList": ["PMC2698179", "19543419"]}, {"Citation": "Celenza G, Iorio R, Cracchiolo S, et al. .. Antimycotic activity of ozonized oil in liposome eye drops against Candida spp. Transl Vis Sci Technol .2020; 9(8): 4.", "ArticleIdList": ["PMC7422790", "32855851"]}, {"Citation": "Bocci V, Larini A, Micheli V.. Restoration of normoxia by ozone therapy may control neoplastic growth: a review and a working hypothesis. J Altern Complement Med. 2005; 11: 257\u2013265.", "ArticleIdList": ["15865491"]}, {"Citation": "Valacchi G, Fortino V, Bocci V.. The dual action of ozone on the skin. Br J Dermatol .2005; 153: 1096\u20131100.", "ArticleIdList": ["16307642"]}, {"Citation": "Sechi LA, Lezcano I, Nunez N, et al. .. Antibacterial activity of ozonized sunflower oil (Oleozon). J Appl Microbiol .2001; 90: 279\u2013284.", "ArticleIdList": ["11168731"]}, {"Citation": "Ugazio E, Tullio V, Binello A, et al. .. Ozonated oils as antimicrobial systems in topical applications. their characterization, current applications, and advances in improved delivery techniques. Molecules .2020; 25: 334.", "ArticleIdList": ["PMC7024311", "31947580"]}, {"Citation": "Spadea L, Tonti E, Spaterna A, Marchegiani A.. Use of ozone-based eye drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol .2018; 9: 287\u2013298.", "ArticleIdList": ["PMC6006625", "29928225"]}, {"Citation": "Marchegiani A, Magagnini M, Cerquetella M, et al. .. Preoperative topical liposomal ozone dispersion to reduce bacterial colonization in conjunctival sac and periocular skin: Preliminary study in dogs. Exp Eye Res .2019; 189: 107848.", "ArticleIdList": ["31634477"]}, {"Citation": "Mazzotta C, Giancipoli E.. Anterior acute uveitis report in a SARS-CoV-2 patient managed with adjunctive topical antiseptic prophylaxis preventing 2019-nCoV spread through the ocular surface route. Int Med Case Rep J .2020; 13: 513\u2013520.", "ArticleIdList": ["PMC7568617", "33116943"]}, {"Citation": "J\u00c1P Gomes, JAP Milhomens Filho. Iatrogenic corneal diseases or conditions. Exp Eye Res .2021; 203: 108376.", "ArticleIdList": ["33279524"]}, {"Citation": "Schrage NF, Flick S, von Fischern T, Reim M, Wenzel M. Temperature changes of the cornea by applying an eye bandage. Ophthalmologe. 1997; 94: 492\u2013495.", "ArticleIdList": ["9333394"]}, {"Citation": "de Wilde AH, Raj VS, Oudshoorn D, et al. .. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-\u03b1 treatment. J Gen Virol .2013; 94(Pt 8): 1749\u20131760.", "ArticleIdList": ["PMC3749523", "23620378"]}, {"Citation": "Caruso A, Caccuri F, Bugatti A, et al. .. Methotrexate inhibits SARS-CoV-2 virus replication \u201cin vitro.\u201d J Med Virol .2020; 93: 1780\u20131785.", "ArticleIdList": ["PMC7891346", "32926453"]}, {"Citation": "Caccuri F, Zani A, Messali S, et al. .. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual. J Transl Med. 2020; 18: 362.", "ArticleIdList": ["PMC7509824", "32967693"]}, {"Citation": "Rizzo R, Neri LM, Simioni C, et al. .. SARS-CoV-2 nucleocapsid protein and ultrastructural modifications in small bowel of a 4-week-negative COVID-19 patient. Clin Microbiol Infect .2021; 27: 936\u2013937.", "ArticleIdList": ["PMC7832059", "33465499"]}, {"Citation": "Wu X, Chen X, Ma Y, et al. .. Analysis of tear inflammatory molecules and clinical correlations in evaporative dry eye disease caused by meibomian gland dysfunction. Int Ophthalmol .2020; 40: 3049\u20133058.", "ArticleIdList": ["PMC7550292", "32601963"]}, {"Citation": "Chotikavanich S, de Paiva CS, Li DQ, et al. .. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci .2009; 50: 3203\u20133209.", "ArticleIdList": ["PMC3594995", "19255163"]}, {"Citation": "Sadhu S, Agrawal R, Pyare R, et al. .. COVID-19: limiting the risks for eye care professionals. Ocul Immunol Inflamm .2020; 28: 714\u2013720.", "ArticleIdList": ["32310028"]}, {"Citation": "Zou L, Ruan F, Huang M, et al. .. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med .2020; 382: 1177\u20131179.", "ArticleIdList": ["PMC7121626", "32074444"]}, {"Citation": "Lu C-W, Liu X-F, Jia Z-F.. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet .2020; 395(10224): e39.", "ArticleIdList": ["PMC7133551", "32035510"]}, {"Citation": "Colavita F, Lapa D, Carletti F, et al. .. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med .2020; 173: 242\u2013243.", "ArticleIdList": ["PMC7175424", "32302380"]}, {"Citation": "Roehrich H, Ching Y, Hou JH. Immunohistochemical study of SARS-CoV-2 viral entry factors in the cornea and ocular surface. Cornea. 2020; 39: 1556\u20131562.", "ArticleIdList": ["32826650"]}, {"Citation": "Cennamo GL, Del Prete A, Forte R, et al. .. Impression cytology with scanning electron microscopy: a new method in the study of conjunctival microvilli. Eye (Lond) .2008; 22: 138\u2013143.", "ArticleIdList": ["17603470"]}, {"Citation": "Li Y-C, Bai W-Z, Hashikawa T.. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol .2020; 92: 552\u2013555.", "ArticleIdList": ["PMC7228394", "32104915"]}, {"Citation": "Seah I, Agrawal R.. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28: 391\u2013395.", "ArticleIdList": ["PMC7103678", "32175797"]}, {"Citation": "Chen L, Liu M, Zhang Z, et al. .. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol .2020; 104: 748\u2013751.", "ArticleIdList": ["PMC7211077", "32265202"]}, {"Citation": "Guan W-J, Ni Z-Y, Hu Y, et al. .. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med .2020; 382: 1708\u20131720.", "ArticleIdList": ["PMC7092819", "32109013"]}, {"Citation": "Wu P, Duan F, Luo C, et al. .. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575\u2013578.", "ArticleIdList": ["PMC7110919", "32232433"]}, {"Citation": "Sun Y, Liu L, Pan X, Jing M.. Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J Ophthalmol .2006; 6: 783\u2013786."}, {"Citation": "Sun K, Gu L, Ma L, Duan Y.. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2. Heliyon .2021; 7(1): e05850.", "ArticleIdList": ["PMC7762714", "33392409"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "5", "Hour": "12", "Minute": "58"}, {"Year": "2021", "Month": "8", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34351367", "PMC8354035", "10.1167/tvst.10.9.7", "2776556"]}}], "PubmedBookArticle": []}